Article
Variation analysis of E1 and E2 in HCV subtypes.
Archives of virology - 1 Oct 2015
Cheng Xue-Di, Xu Hua-Feng, Wei Xue-Mei, Zhou Hai-Zhou
Abstract excerpt
Pegylated interferon and ribavirin combination therapy effectively suppresses viral replication in 50 %-60 % of hepatitis C virus (HCV)-infected patients. However, HCV-infected patients often display varied responses to therapy, and strains of subtype lb (the most widespread HCV subtype worldwide) have more-severe clinical manifestations, greater viral loads, and poorer responses to interferon treatment....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
